| P50 | author | Lance R McMahon | Q60311068 |
| P2093 | author name string | Jennifer L Stewart | |
| P2860 | cites work | Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase | Q24555807 |
| | CB2 receptor-mediated migration of immune cells: it can go either way | Q24643591 |
| | Activation of G-proteins in brain by endogenous and exogenous cannabinoids | Q24647703 |
| | The endocannabinoid system as a target for the treatment of cannabis dependence | Q24648135 |
| | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ | Q28298445 |
| | Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol | Q28833498 |
| | Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 |
| | Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 |
| | Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 |
| | Pharmacological characterization of GPR55, a putative cannabinoid receptor | Q33869340 |
| | Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs | Q34028114 |
| | Animal models of cannabinoid reward | Q34098204 |
| | Pharmacokinetics and pharmacodynamics of cannabinoids | Q34185013 |
| | Chronic Δ9‐tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross‐tolerance among cannabinoids | Q34636231 |
| | Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. | Q35623063 |
| | An overview of drug combination analysis with isobolograms | Q36466884 |
| | Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain | Q36912778 |
| | Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence | Q36932053 |
| | Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception | Q37162136 |
| | Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice | Q37214542 |
| | Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates | Q37239653 |
| | Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation | Q42434209 |
| | Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease | Q42851005 |
| | Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew | Q43648938 |
| | (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide | Q43703172 |
| | Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys. | Q44625328 |
| | Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice | Q44923318 |
| | Discriminative stimulus effects of anandamide in rats | Q45084272 |
| | In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity | Q45096581 |
| | Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism | Q45100238 |
| | The biodisposition and metabolism of anandamide in mice | Q45105707 |
| | Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys | Q45108581 |
| | Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. | Q45110083 |
| | Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 |
| | Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys | Q45261514 |
| | Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. | Q48099000 |
| | Large receptor reserve for cannabinoid actions in the central nervous system. | Q48299894 |
| | The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport | Q48315882 |
| | Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats | Q48485540 |
| | Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma | Q48513242 |
| | Guide to Receptors and Channels (GRAC), 4th Edition | Q56639335 |
| | Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats | Q60690625 |
| P433 | issue | 2b | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| | niacinamide | Q192423 |
| | anandamide | Q410228 |
| | cannabinoids | Q422936 |
| P304 | page(s) | 655-666 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys | |
| P478 | volume | 164 | |